Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Feline Medicine and Surgery
|
September 11, 2016
Ultrasonographic, endoscopic and histological appearances of the caecum in cats presenting with chronic clinical signs of caecocolic disease
Harriet Hahn, Pascaline Pey, Aurélie Baril, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie
|
January 29, 2008
An atypical case of histiocytic sarcoma in a Wistar rat (Rattus norvegicus)
Anne-Laure Bauchet, Marie-Claude Fouque, Sara Belluco, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie
|
May 10, 2008
A mammary gland adenomyoepithelioma in a C57BL/6 mouse
Anne-Laure Bauchet, Laëtitia Elies, Pierre Maliver, et al.
Phytochemistry
|
July 28, 2004
A two-dimensional proteome map of maize endosperm
Valérie Méchin, Thierry Balliau, Sophie Château-Joubert, et al.
Oncotarget
|
May 26, 2018
PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
Caroline Spasojevic, Elisabetta Marangoni, Sophie Vacher, et al.
International Journal of Cancer
|
December 22, 2015
Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers
Rana Hatem, Dalila Labiod, Sophie Château-Joubert, et al.
Cancer Research
|
February 12, 2021
YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer
Hazel M Quinn, Regina Vogel, Oliver Popp, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 6, 2013
Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters
Vincent Petit, Gérald Massonnet, Zofia Maciorowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2018
Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy
Pierre Foidart, Cassandre Yip, Jean Radermacher, et al.
Journal of Hematology & Oncology
|
September 9, 2021
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
Ivan Bièche, Florence Coussy, Rania El-Botty, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Feline Medicine and Surgery
|
September 11, 2016
Ultrasonographic, endoscopic and histological appearances of the caecum in cats presenting with chronic clinical signs of caecocolic disease
Harriet Hahn, Pascaline Pey, Aurélie Baril, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie
|
January 29, 2008
An atypical case of histiocytic sarcoma in a Wistar rat (Rattus norvegicus)
Anne-Laure Bauchet, Marie-Claude Fouque, Sara Belluco, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie
|
May 10, 2008
A mammary gland adenomyoepithelioma in a C57BL/6 mouse
Anne-Laure Bauchet, Laëtitia Elies, Pierre Maliver, et al.
Phytochemistry
|
July 28, 2004
A two-dimensional proteome map of maize endosperm
Valérie Méchin, Thierry Balliau, Sophie Château-Joubert, et al.
Oncotarget
|
May 26, 2018
PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
Caroline Spasojevic, Elisabetta Marangoni, Sophie Vacher, et al.
International Journal of Cancer
|
December 22, 2015
Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers
Rana Hatem, Dalila Labiod, Sophie Château-Joubert, et al.
Cancer Research
|
February 12, 2021
YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer
Hazel M Quinn, Regina Vogel, Oliver Popp, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 6, 2013
Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters
Vincent Petit, Gérald Massonnet, Zofia Maciorowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2018
Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy
Pierre Foidart, Cassandre Yip, Jean Radermacher, et al.
Journal of Hematology & Oncology
|
September 9, 2021
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
Ivan Bièche, Florence Coussy, Rania El-Botty, et al.
Page
of 2